Stock Scorer

Akzo Nobel N.V. (AKZA.AS)

Akzo Nobel N.V. reported revenue of 10.2B EUR for the year ending 31 December 2025, down 5.2% from 10.7B a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in EUR. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in EUR.
FigurePeriodAmountYear on year
Revenue 2025 · ending 31 December 2025 10.2B -5.2%
Gross Profit 2025 · ending 31 December 2025 4B -6.6%
Operating Income 2025 · ending 31 December 2025 1.2B +26.9%
Net Income 2025 · ending 31 December 2025 671M +13.3%
Cost of Revenue 2025 · ending 31 December 2025 6.1B -4.2%
Operating Cash Flow 2025 · ending 31 December 2025 915M +36.0%
Free Cash Flow 2025 · ending 31 December 2025 606M +65.1%
Shares Outstanding 2026 · ending 1 January 2026 172.1M +0.3%
EPS 2025 · ending 31 December 2025 3.69 +16.8%

Revenue and profit by financial year

As filed, in EUR. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 10.2B1.2B671M606M
20242024-12-31 10.7B917M592M367M
20232023-12-31 10.7B1B483M840M
20222022-12-31 10.8B708M378M-29M
20212021-12-31 9.6B1.1B865M317M
20202020-12-31 8.5B963M671M962M

Every period

Revenue Annual

PeriodEndingRevenue
FY252025-12-3110.2B
FY242024-12-3110.7B
FY232023-12-3110.7B
FY222022-12-3110.8B
FY212021-12-319.6B

Gross Profit Annual

PeriodEndingGross Profit
FY252025-12-314B
FY242024-12-314.3B
FY232023-12-314.2B
FY222022-12-313.9B
FY212021-12-313.9B

Operating Income Annual

PeriodEndingOperating Income
FY252025-12-311.2B
FY242024-12-31917M
FY232023-12-311B
FY222022-12-31708M
FY212021-12-311.1B

Net Income Annual

PeriodEndingNet Income
FY252025-12-31671M
FY242024-12-31592M
FY232023-12-31483M
FY222022-12-31378M
FY212021-12-31865M

Cost of Revenue Annual

PeriodEndingCost of Revenue
FY252025-12-316.1B
FY242024-12-316.4B
FY232023-12-316.4B
FY222022-12-316.9B
FY212021-12-315.7B

Operating Cash Flow Annual

PeriodEndingOperating Cash Flow
FY252025-12-31915M
FY242024-12-31673M
FY232023-12-311.1B
FY222022-12-31263M
FY212021-12-31605M

Free Cash Flow Annual

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
FY252025-12-31606M
FY242024-12-31367M
FY232023-12-31840M
FY222022-12-31-29M
FY212021-12-31317M

Shares Outstanding Annual

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
FY262026-01-01172.1M
FY252025-01-01171.5M
FY242024-01-01171.3M
FY232023-01-01175.1M
FY212021-01-01192.1M

EPS Annual

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
FY252025-12-313.69
FY242024-12-313.16
FY232023-12-312.58
FY222022-12-312.01
FY212021-12-310.04